Potentiation of the cytotoxicity of carboquone by flavone acetic acid combined with hyperthermia

Anti-Cancer Drugs

Volumn 8, Issue 8, 1997, Pages 778-783

  Takeuchi, Hideya ^a   Baba, Hideo ^a   Inutsuka, Sadaaki ^a   Maehara, Yoshihiko ^b   Sugimachi, Keizo ^a,b  

^a KYUSHU UNIVERSITY HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Carboquone; Flavone acetic acid; Hyperthermia; Tumor blood flow

Indexed keywords

CARBOQUONE; MITOFLAXONE; MITOMYCIN C;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; HYPERTHERMIA; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBAZILQUINONE; CELL HYPOXIA; COMBINED MODALITY THERAPY; DRUG SYNERGISM; FLAVONOIDS; HYPERTHERMIA, INDUCED; MALE; MELANOMA, EXPERIMENTAL; MICE; TUMOR CELLS, CULTURED;

EID: 0030827662     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-199709000-00007     Document Type: Article

References (35)

1. Knapp WH, Debatin J, Layer K, et al. Selective drug-induced reduction of blood flow in tumor transplants. Int J Radiat Oncol Biol Phys 1985; 11: 1357-66.
2. Stratford IJ, Adams GE, Godden J, Nolan N, Howells N, Timpson N. Potentiation of the anti-tumor effect of melphalan by the vasoactive agents, hydralazine. Br J Cancer 1988; 58: 122-7.
3. Kerr DJ, Kaye SB, Cassidy J, et al. Phase I and pharmacokinetic study of flavone acetic acid. Cancer Res 1987; 47: 6776-81.
4. Weiss RB, Greene RF, Knight RD, el al. Phase I and clinical pharmacology study of intravenous flavone acetic acid (NSC 347512). Cancer Res 1988; 48: 5878-82.
5. Hill S, Williams KB, Denekamp J. Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumor action. Eur J Cancer Clin Oncol 1989; 25: 1419-24.
6. Bibby MC, Double JA, Phillips RM, Loadman PM. Factors involved in the anti-cancer activity of the investigational agents LM985 (flavone acetic acid ester) and LM975 (flavone acetic acid). Br J Cancer 1987; 55: 159-63.
7. Murray JC, Smith KA, Stern DM. Flavone acetic acid potentiates the induction of endothelial procoagulant activity by tumour necrosis factor. Eur J Cancer 1991; 27: 765-70.
8. Nakazato II, Ichihashi H, Kondo T. Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer. Cooperative Study Group of Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group. Jpn J Cancer Chemother 1986; 13: 308-18 (in Japanese).
9. Maehara Y, Anai Y, Kusumoto H, Sugimachi K. Poorly differentiated human gastric carcinoma is more sensitive to antitumor drugs than is well differentiated carcinoma. Eur J Surg Oncol 1987; 13: 203-6.
10. Kohnoe S, Moriguchi S, Emi Y. et al. Lung adenocarcinoma is more sensitive than gastric adenocarcinoma to anticancer drugs in vitro. Eur J Surg Oncol 1991; 17: 47-50.
11. Kusumoto T, Maehara Y, Sakaguchi Y, Saku M, Sugimachi K. Hypoxia enhances the lethality of mitomycin C and carhoquone against human malignant tumor cells in vitro. Eur Surg Res 1989; 21: 224-31.
12. Kusumoto T, Maehara Y, Sakaguchi Y, Kohnoe S, Emi Y, Sugimachi K. Sarcoma-180 cells and human colorectal tumor cells under in vitro hypoxic conditions are more sensitive to mitomycin C and carhoquone. Eur J Surg Oncol 1991; 17: 358-63.
13. Herman TS, Jochelson MS, Teicher BA, et al. A phase I-II trial of cisplatin, hyperthermia and radiation in patients with locally advanced malignancies. Int J Radiat Oncol Biol Phys 1989; 17: 1273-79.
14. Fujimura T, Yonemura Y, Fushida S. et al. Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation. Cancer 1990; 65: 65-71.
15. Herman TS, Teicher BS, Jochelson M, Clark J, Svensson G, Coleman CN. Rationale for use of local hyperthermia with radiation therapy and selected anticancer drugs in locally advanced human malignancies. Int J Hyperthermia 1988; 4: 143-58.
16. Baba H, Siddk ZH, Strebel FR, Jenkins GN, Bull JM. Increased therapeutic gain of combined cis-diamminedichloroplatinum(H) and whole body hyperthermia therapy to optimal heat/drug scheduling. Cancer Res 1989; 49: 7041-4.
17. Baba H, Stephens C, Strebel FR, et al. Protective effect of ICRF-187 against normal tissue injury induced by adriamycin in combination with whole body hyperthermia. Cancer Res 1991; 51: 3568-77.
18. Bull JM, Chretien PB. Editorial: heat as cancer therapy. J Am Med Ass 1976; 235: 2223.
19. Sakaguchi Y, Maehara Y, Baba H, Kusumoto T, Sugimachi K, Newman RA. Flavone acetic acid increase the antitumor effect of hyperthermia in mice. Cancer Res 1992; 52: 3306-9.
20. Power JA, Harris JW. Response of extremely hypoxic cells to hyperthermia: survival and oxygen enhancement ratios. Radiology 1977; 123: 767-70.
21. Takeuchi H, Baba H, Maehara Y, Sugimachi K, Newman RA. Flavone acetic acid increases the cytotoxicity of mitomycin C when combined with hyperthermia. Cancer Chemother Pharmacol 1996; 38: 1-8.
22. Carlsson G, Gullberg B, Hafstrom I. Estimation of liver tumor volume using different formulas-an experimental study in rats. J Cancer Res Clin Oncol 1983; 105: 20-3.
23. Teicher BA, Lazo JS, Sartorelli AC. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res 1981; 41: 73-81.
24. Mahadevan V, Malik STA, Meager A, Fiers W, Lewis GP, Hart IR. Role of tumor necrosis factor in flavone acetic-acid induced tumor vasculature shutdown. Cancer Res 1990; 50: 5537-42.
25. Murray JC, Smith KA, Thurston G. Flavone acetic acid induces coagulopathy in mice. Br J Cancer 1989; 60: 729-33.
26. Watts ME, Woodcock M. Flavone acetic acid induced changes in human endothelial permeability: potentiation by tumor-conditioned medium. Eur J Cancer 1992; 28A: 1628-32.
27. Rubin J, Ames MM, Schutt AJ, Nichols WL, Bowie EJ, Kovach JS. Flavone-8-acetic acid inhibits ristocetin-induced platelet agglutination and prolongs bleeding time. Lancet 1987; 7: 1081-2.
28. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-65.
29. Overgaard J. Influence of extracellular pH on the viability and morphology of tumor cells exposed to hyperthermia. J Natl Cancer Inst 1976; 56: 1243-50.
30. Overgaard J, Bichel P. The influence of hypoxia and acidity on the hyperthermia response of malignant cells in vitro. Radiology 1977; 123: 511-4.
31. Nakao H, Arakawa M. Antileukemic agents I. Some of 2,5-disubstituted p-benzoquinones. Chem Pharm Bull 1972; 20: 1962-7.
32. Maehara Y, Anai H, Kusumoto H, Sugimachi K. Carbo quone alters the protein synthesis of Chinese hamster V79 cell. Oncology 1987; 44: 253-6.
33. Kennedy KA, Rockwell S, Sartorelli AC. Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells. Cancer Res 1980; 40: 2356-60.
34. Bicher HI, Hetzel FW, Sandhu TS, et al. Effects of hyperthermia on normal and tumor microenvironment. Radiology 1980; 137: 523-30.
35. Song CW, Kang MS, Rhee JG, Levitt SH. The effect of hyperthermia on vascular function, pH, and cell survival. Radiology 1980; 137: 795-803.